Related Experiment Video
Updated: Mar 24, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Autologous stem cell transplant for severe, progressive juvenile systemic sclerosis
Shaikha Alqahtani1, Fabiana Cacace1,2, Andrea Bauchat1
1Pediatric Transplant and Cellular Therapy, Duke University, Durham, NC 27705, United States.
Autologous stem cell transplantation shows promise for treating juvenile systemic sclerosis (jSSc), a rare autoimmune condition in children. This approach led to clinical improvement in a patient with difficult-to-treat jSSc.
Area of Science:
- Pediatric Rheumatology
- Autoimmune Diseases
- Stem Cell Transplantation
Background:
- Juvenile systemic sclerosis (jSSc) is a rare, chronic autoimmune condition affecting children and adolescents.
- jSSc presents with significant morbidity, including skin thickening (scleroderma), organ toxicity, and limited treatment options.
Purpose of the Study:
- To report the outcomes of autologous stem cell transplantation in a patient with refractory juvenile systemic sclerosis.
Main Methods:
- A case report detailing the treatment of a 17-year-old patient with refractory jSSc.
- Administration of autologous stem cell transplantation.
Main Results:
- The patient experienced notable clinical improvement following the transplantation.
Conclusions:
- Autologous stem cell transplantation may be a viable therapeutic option for refractory juvenile systemic sclerosis.
- Further research is warranted to evaluate the efficacy and safety of this treatment in a larger cohort.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Adult Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Mesenchymal Stem Cells

